Veracyte reported $78.32M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
Agilent USD 283.59M 280.59M Jul/2025
Arrowhead Research USD 138.14M 137.91M Jun/2025
Bruker USD 151.72M 149.92M Jun/2025
Exact Sciences USD 189.22M 187.33M Jun/2025
Illumina USD 154M 152M Jun/2025
Laboratory Of America USD 82.9M 75.3M Jun/2025
Ligand Pharmaceuticals USD 19.41M 19.39M Jun/2025
Myriad Genetics USD 900K 0 Mar/2025
Roche Holding CHF 107M 0 Jun/2024
Siemens EUR 787.07M 1.61B Jun/2025
Sonic Healthcare AUD 4.15B 467K Dec/2024
Thermo Fisher Scientific USD 377.49M 66.51M Jun/2025
Veracyte USD 78.32M 78.24M Jun/2025
Waters USD 59.51M 57.88M Jun/2025